Edward Gerstenfeld of the School of Medicine comments on embracing a new heart-failure medicine.
Perelman School of Medicine
Mariell Jessup of the School of Medicine comments on new developments in heart-failure treatment.
CHICAGO -- CPR quality is worse during in-hospital cardiac arrests occurring overnight than those that happen during the day, according to a new University of Pennsylvania School of Medicine study that will be presented at the American Heart Association's annual Scientific Sessions on November 14.
Penn-Led International Study Finds No Difference in Nonsuicide Mortality Between Two Anti-Psychotic Drugs
PHILADELPHIA - The potential for harmful side effects associated with anti-psychotic medications for treating schizophrenia is a frustration for mental-health professionals who must balance this with the positive benefits of drugs. For example, the issue of the antipsychotic drug ziprasidone lengthening the QTc interval, a possible indicator of life-threatening heart arrhythmias, has demanded much attention among clinicians since the drug was introduced in 2001.
Gone are the days when a doctor’s only way of helping patients is by treating the disease after symptoms have started. Instead, a new approach to medicine, called “Desktop Medicine” is emerging, in which the emphasis shifts from diagnosing diseases and treating symptoms to identifying risk-factors for medical conditions such as hypertension and osteoporosis, and intervening before they develop. The commentary appears in the current issue of the Journal of the American Medical Association.
David Sarwer of the School of Medicine comments on the effect overweight people might have on their friends’ eating habits.
Yvonne Paterson of the School of Medicine is cited for the development of Advaxis’ technology.